Getting at the variable expressivity of Von Willebrand disease

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 144-148

  Levy, G ^a   Ginsburg, D ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

ABO blood group; Thrombosis; Variable expressivity; Von Willebrand disease; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

BLOOD GROUP ABO SYSTEM; CONFERENCE PAPER; FACTORIAL ANALYSIS; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; RISK FACTOR; VEIN THROMBOSIS; VON WILLEBRAND DISEASE;

EID: 0034924905     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616211     Document Type: Conference Paper

References (40)

1. High plasma concentration of factor VIII is a major risk factor for venous thromboembolism
2. High levels of factor VIII and venous thrombosis
3. The future of genetic studies of complex human diseases
4. Von Willebrand disease
5. A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients
6. Genetic heterogenity of severe von Willebrand disease type III in the German population
7. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing
8. Epidemiological investigation of the prevalence of von Willebrand's disease
9. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin
10. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: Detection by exonic PCR-restriction fragment length polymorphism analysis
11. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families
12. Effects of the mutant von Willebrand factor gene in von Willebrand disease
13. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor
14. Recessive inheritance of von Willebrand's disease type I
15. Hereditär Pseudohemofili
16. Laboratory diagnosis of von Willebrand's disease
17. The effects of epinephrine infusion in patients with von Willebrand's disease
18. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa
19. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level
20. Structures common to different types of glycans
21. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor
22. The effect of ABO blood group on the diagnosis of von Willebrand Disease
23. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase
24. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A
25. Possible effect of secretor locus on plasma concentration of Factor VIII and von Willebrand factor
26. 1 levels in type 1 von Willebrand disease correlate with impaired platelet function in a high shear stress system
27. Risk factors for venous thrombosis: Prevalence, risk, and interaction
28. Moderation of hemophilia A phenotype by the factor V R506Q mutation
29. Low prevalence of the factor V Leiden mutation among "severe" hemophilics with a "milder" bleeding diathesis
30. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
31. A normal beta-globin allele as a modifier gene ameliorating the severity of alpha-thalassemia in mice
32. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg
33. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
34. Molecular genetics of von Willebrand disease
35. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
36. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11
37. The RIIIS/J inbred mouse strain as a model for von Willebrand disease
38. Von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene
39. Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen
40. a blood group carbohydrate structure in human gastrointestinal mucosa and cancer